No Data
No Data
Integrated BioPharma Reports Results for Its Quarter Ended March 31, 2024
HILLSIDE, NJ / ACCESSWIRE / May 10, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2024.Revenue for each of the
INTEGRATED BIOPHARMA INC | 10-Q: Quarterly report
Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2023
HILLSIDE, NJ / ACCESSWIRE / February 12, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2023.Revenue for the
Integrated BioPharma Reports Results
Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2023
HILLSIDE, NJ / ACCESSWIRE / November 9, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2023.Revenue for the
Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2023
HILLSIDE, NJ / ACCESSWIRE / September 15, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2023.Rev
No Data